drugset / Trial / NCT00157547

Quantitative EEG (QEEG) as a Predictor of Treatment Outcome in Depression

NCT00157547

Non-randomizedParallel-groupOpen-labelTreatment

Summary

The purpose of the study is to try to see if antidepressant medications cause changes in QEEG measurements in the brain. QEEG is a mathematical analysis of electrical currents in the brain using electrodes placed on the scalp. Previous studies have shown that mood improvement (clinical response) caused by antidepressant medications was preceded by changes in QEEG measurements in the brain.

Timeline

Start
2003-04
Primary completion
2006-08
Completion
2006-08

Drugs

EvaluationDrugModalityDoseRoute
Subject Citalopram Small molecule
Subject Escitalopram Small molecule
Subject Fluoxetine Small molecule
Subject Fluvoxamine Unknown
Subject Paroxetine Small molecule
Subject Sertraline Small molecule
Subject Venlafaxine Small molecule